Skip to content

ERAS Protocol in Laparoscopic Hysterectomy

The Impact of Implementing ERAS Protocol on Healthcare Costs in Patients Undergoing Laparoscopic Hysterectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03986450
Enrollment
60
Registered
2019-06-14
Start date
2019-06-20
Completion date
2019-07-18
Last updated
2019-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Keywords

Enhanced recovery after surgery, Laparoscopic hysterectomy

Brief summary

ERAS protocol has been shown to improve patient comfort and reduce the length of hospital stay. This study aimed to investigate the impact of implementing ERAS protocols on healthcare costs in patients undergoing a laparoscopic hysterectomy.

Detailed description

ERAS protocol has been shown to improve patient comfort and reduce the length of hospital stay in various kinds of surgical procedures. This study aimed to investigate whether ERAS protocol has an impact on healthcare costs in patients undergoing a laparoscopic hysterectomy. Patients scheduled for laparoscopic hysterectomy will be allocated to one of the study groups: ERAS group patients will receive ERAS protocol during the perioperative period; Conventional care groups will undergo standard abdominal hysterectomy without the implementation of ERAS protocol. The groups will be compared with respect to the length of hospital stay, rehospitalizations, and healthcare costs.

Interventions

OTHEREnhanced recovery after surge(ERAS) protocol

The components of ERAS multidisciplinary pathway concerning preoperative, operative, and postoperative period are as follows: 1. Preoperative care: Counseling before hospital admission Fluid, and carbohydrate loading Avoiding prolongation of the fasting period Avoiding bowel preparation or its application only in selective cases Application of antibiotic prophylaxis Application of thromboprophylaxis 2. Perioperative care: Use of short-acting anesthetic agents Application of midthoracic, epidural anesthesia/analgesia Refraining from using drains Refraining from salt, and water overload Maintenance of normothermia Postoperative care: Application of midthoracic, epidural anesthesia/analgesia Prevention of nausea, and vomiting Refraining from salt, and water overload Earlier removal of catheters Initiation of oral intake at an early period Use of nonopioid oral analgesics/NSAIDs Early mobilization

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Must be scheduled for laparoscopic hysterectomy

Exclusion criteria

* American Society of Anesthesiologists (ASA) class IV * Development of complications during surgery * Body mass index \> 40 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Healthcare costsUp to one monthHospital costs will be obtained from the accounting office of the hospital

Secondary

MeasureTime frameDescription
Length of stayUp to one monthLength of hospital stay

Countries

Turkey (Türkiye)

Contacts

Primary ContactAysu Akca, MD
aysuakca4@gmail.com+902124041500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026